SCHEMBL12340201

SCHEMBL12340201

Fc1nc2nc3cc4nc5nc(F)c(F)nc5nc4cc3nc2nc1F

nearest known ligand 0.38

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 1/20 0.38
KDM4E B2RXH2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12340159 0.73 NQO2 (0.40) KDM4E
SCHEMBL12340196 0.69 GLP1R (0.36) NQO1KDM4E
SCHEMBL12340139 0.67
SCHEMBL12340146 0.66 MAPT (0.46) KDM4E
SCHEMBL12344246 0.63 NQO1 (0.33) NQO1
SCHEMBL4311227 0.62 MEN1 (0.33)
SCHEMBL12340182 0.60 TDP1 (0.36) KDM4E
SCHEMBL12340162 0.59
SCHEMBL2252791 0.58 ALOX15 (0.35) NQO1KDM4E
SCHEMBL5096456 0.58 MAPT (0.62) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8268457-B2 Organic electroluminescent device and material for organic electroluminescent device IDEMITSU KOSAN CO., LTD. (JP) 2012-09-18 US disclosed
US-8268457-B2 Organic electroluminescent device and material for organic electroluminescent device IDEMITSU KOSAN CO., LTD. (JP) 2012-09-18 US disclosed
US-20090167167-A1 Organic electroluminescent device and material for organic electroluminescent device IDEMITSU KOSAN CO., LTD. (JP) 2009-07-02 US disclosed
US-20090167167-A1 Organic electroluminescent device and material for organic electroluminescent device IDEMITSU KOSAN CO., LTD. (JP) 2009-07-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090167167-A1 Organic electroluminescent device and material for organic electroluminescent device ELAVL1, L1CAM, OR10J3 NQO1 1042/4885KDM4E 1764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.